News Releases










News Releases

14 May 2019
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement  TORONTO , May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to announce that it has entered into a multi-year supply agreement with
09 May 2019
Cronos Group Inc. Announces First Quarter 2019 Results
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs , a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to Cultivate Psychoactive Cannabis in Colombia Spinach™ Partners with Arrive Alive DRIVE SOBER® Cronos Group
07 May 2019
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel
Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO , May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it is expanding its global infrastructure
08 March 2019
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.

TORONTO , March 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (NYSE: MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group . Altria also has a warrant to acquire additional ownership in Cronos Group , which is exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55% and provide Cronos Group with additional proceeds of approximately C$1.4 billion .

04 March 2019
Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation
TORONTO , March 04, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation (" Whistler "), representing approximately 19 percent
23 January 2019
Cronos Group Inc. Announces Closing of $65 Million Credit Facility
TORONTO , Jan. 23, 2019 /PRNewswire/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (" Cronos Group " or the " Company ") today announced that it has entered into a credit agreement (the " Credit Agreement ") with Canadian Imperial Bank of Commerce (" CIBC "), as administrative agent and



Print Page Sign Up for Email Alerts RSS Feeds Financial Tearsheet